PharmaCyte Biotech Inc (PMCB)
2.20
+0.07
(+3.29%)
USD |
NASDAQ |
Apr 24, 16:00
2.13
-0.07
(-3.18%)
After-Hours: 20:00
PharmaCyte Biotech Net Income (TTM): -1.139M for Jan. 31, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| January 31, 2024 | -1.139M |
| October 31, 2023 | -1.284M |
| July 31, 2023 | -5.954M |
| April 30, 2023 | -4.316M |
| January 31, 2023 | -5.612M |
| October 31, 2022 | -5.660M |
| July 31, 2022 | -4.759M |
| April 30, 2022 | -4.239M |
| January 31, 2022 | -3.776M |
| October 31, 2021 | -3.722M |
| July 31, 2021 | -3.693M |
| April 30, 2021 | -3.551M |
| January 31, 2021 | -3.342M |
| October 31, 2020 | -3.460M |
| July 31, 2020 | -3.577M |
| April 30, 2020 | -3.827M |
| January 31, 2020 | -4.215M |
| October 31, 2019 | -4.016M |
| July 31, 2019 | -3.986M |
| April 30, 2019 | -4.067M |
| January 31, 2019 | -4.224M |
| October 31, 2018 | -5.578M |
| July 31, 2018 | -6.356M |
| April 30, 2018 | -6.829M |
| January 31, 2018 | -6.688M |
| Date | Value |
|---|---|
| October 31, 2017 | -5.940M |
| July 31, 2017 | -5.100M |
| April 30, 2017 | -4.444M |
| January 31, 2017 | -4.411M |
| October 31, 2016 | -4.920M |
| July 31, 2016 | -5.581M |
| April 30, 2016 | -6.064M |
| January 31, 2016 | -7.763M |
| October 31, 2015 | -7.430M |
| July 31, 2015 | -9.858M |
| April 30, 2015 | -9.928M |
| January 31, 2015 | -23.58M |
| October 31, 2014 | -22.58M |
| July 31, 2014 | -24.17M |
| April 30, 2014 | -27.25M |
| January 31, 2014 | -11.11M |
| October 31, 2013 | -11.03M |
| July 31, 2013 | -5.753M |
| April 30, 2013 | -1.597M |
| January 31, 2013 | -1.774M |
| October 31, 2012 | -1.670M |
| July 31, 2012 | -1.724M |
| April 30, 2012 | -1.899M |
| January 31, 2012 | -2.488M |
| October 31, 2011 | -2.341M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-5.954M
Minimum
Jul 2023
-1.139M
Maximum
Jan 2024
-3.910M
Average
-3.906M
Median
Net Income (TTM) Benchmarks
| CEL-SCI Corp | -31.05M |
| AIM ImmunoTech Inc | -28.96M |
| IGC Pharma Inc | -14.14M |
| NovaBay Pharmaceuticals Inc | -9.64M |
| Protalix BioTherapeutics Inc | 8.312M |